🔗 Permalink

Inventor profile of:

Michael G. Johnson

City:

San Francisco, California

Country:

United States

Published Applications:

Last publication date:

2026-04-23

Top Assignees for applications by Michael G. Johnson

The entities that hold a legal rights for patent applications filed by inventor Johnson Michael G.:

Amgen Inc. 14 Thousand Oaks, CA United States
Amgen SF, LLC 4 South San Francisco, CA United States
Azkarra Therapeutics, Inc. 1 South San Francisco, CA United States
Oregon Health & Science University 1 Portland, OR United States

Recent patent applications by Johnson Michael G.

Michael G. Johnson from San Francisco, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-04-23

US20260109686A1

Chemistry; metallurgy

PYRIDAZIN-3(2H)-ONE AND PYRIDIN-2(1H)-ONE PARP INHIBITOR COMPOUNDS

#2 | 2026-03-19

US20260078091A1

Chemistry; metallurgy

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer

#3 | 2026-02-26

US20260055079A1

Chemistry; metallurgy

PHTHALAZINONE COMPOUNDS AS PARP7 INHIBITORS

#4 | 2024-09-12

US20240300892A1

Chemistry; metallurgy

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer

#5 | 2023-02-16

US20230052348A1

Chemistry; metallurgy

Compounds that inhibit MCL-1 protein

#6 | 2022-06-02

US20220169611A1

Chemistry; metallurgy

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer

#7 | 2021-07-29

US20210230189A1

Chemistry; metallurgy

Compounds that inhibit MCL-1 protein

#8 | 2021-06-17

US20210179560A1

Chemistry; metallurgy

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer

#9 | 2019-02-28

US20190062276A1

Chemistry; metallurgy

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer

#10 | 2017-05-25

US20170144971A1

Chemistry; metallurgy

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer

#11 | 2016-11-17

US20160333017A1

Chemistry; metallurgy

Heterocyclic compounds and their uses

#12 | 2016-05-19

US20160137667A1

Chemistry; metallurgy

Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer

#13 | 2014-10-23

US20140315895A1

Chemistry; metallurgy

Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer

#14 | 2014-08-21

US20140235629A1

Chemistry; metallurgy

Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer

#15 | 2011-12-29

US20110319378A1

Chemistry; metallurgy

Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer

#16 | 2011-03-10

US20110060011A1

Chemistry; metallurgy

Oxazole compounds compositions and methods of use

#17 | 2010-12-30

US20100331306A1

Chemistry; metallurgy

HETEROCYCLIC COMPOUNDS AND THEIR USES

#18 | 2010-12-30

US20100331293A1

Chemistry; metallurgy

Quinoline derivitives and their uses

#19 | 2008-12-18

US20080312270A1

Chemistry; metallurgy

Compounds and methods useful for treating asthma and allergic inflammation

#20 | 2006-06-01

US20060116388A1

Chemistry; metallurgy

CXCR3 antagonists

#21 | 2006-05-30

US10231895

Substituted Quinazolin-4(3H)-one compounds, compositions, and methods for their use

#22 | 2006-03-30

US20060069127A1

Chemistry; metallurgy

Imidazolo-related compounds, compositions and methods for their use

#23 | 2006-03-30

US20060069106A1

Chemistry; metallurgy

Tetrahydroquinazolin-4(3H)-one-related and tetrahydropyrido[2,3-]pyrimidin-4(3H)-one-related compounds, compositions and methods for their use

#24 | 2006-03-30

US20060069099A1

Chemistry; metallurgy

Compounds, compositions and methods for prevention and treatment of inflammatory and immunoregulatory disorders and diseases

#25 | 2005-11-15

US10015532

Substituted pyrido[2,3-d]pyrimidines and methods for their use

#26 | 2005-04-07

US20050075333A1

Chemistry; metallurgy

CXCR3 antagonists

InventorID:

880975 ⎘